These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


233 related items for PubMed ID: 15219287

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Preparation and biodistribution of yttrium-90 Lipiodol in rats following hepatic arterial injection.
    Wang SJ, Lin WY, Chen MN, Shen LH, Tsai ZT, Ting G.
    Eur J Nucl Med; 1995 Mar; 22(3):233-6. PubMed ID: 7789396
    [Abstract] [Full Text] [Related]

  • 23. Synthetic approaches and bio-distribution studies of [11C]methyl-phenidate.
    Patt M, Solbach C, Wüllner U, Blocher A, Stahlschmidt A, Gündisch D, Kovar KA, Machulla HJ.
    J Pharm Pharm Sci; 2007 Mar; 10(2):312s-320s. PubMed ID: 17718934
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A report on the implementation aspects of the International Atomic Energy Agency's first doctoral coordinated research project, "Management of liver cancer using radionuclide methods with special emphasis on trans-arterial radio-conjugate therapy and internal dosimetry".
    Padhy AK, Dondi M.
    Semin Nucl Med; 2008 Mar; 38(2):S5-12. PubMed ID: 18243843
    [Abstract] [Full Text] [Related]

  • 26. (188)Re-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation study.
    Lambert B, Bacher K, Defreyne L, Van Vlierberghe H, Jeong JM, Wang RF, van Meerbeeck J, Smeets P, Troisi R, Thierens H, De Vos F, Van de Wiele C.
    Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):344-52. PubMed ID: 16333675
    [Abstract] [Full Text] [Related]

  • 27. Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma.
    De Ruyck K, Lambert B, Bacher K, Gemmel F, De Vos F, Vral A, de Ridder L, Dierckx RA, Thierens H.
    J Nucl Med; 2004 Apr; 45(4):612-8. PubMed ID: 15073257
    [Abstract] [Full Text] [Related]

  • 28. Boron-lipiodol: a potential new drug for the treatment of liver tumors.
    Lin WY, Chi CW, Ho YJ, Wu IC, Chung YT, Chen SD, Chou FI, Kai JJ, Lui WY, Chen TJ, Lin Y.
    Anticancer Res; 2002 Apr; 22(6C):3989-92. PubMed ID: 12553023
    [Abstract] [Full Text] [Related]

  • 29. P-31 MR spectrum and histologic changes after intrahepatic arterial injection of iodized oil in normal and cirrhotic rat liver.
    Ohkusa A, Yoshioka H, Ishida O.
    Acta Radiol; 1992 Sep; 33(5):468-73. PubMed ID: 1327027
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. In vivo microscopy of the liver after injection of Lipiodol into the hepatic artery and portal vein in the rat.
    Kan Z, Ivancev K, Hägerstrand I, Chuang VP, Lunderquist A.
    Acta Radiol; 1989 Sep; 30(4):419-25. PubMed ID: 2550044
    [Abstract] [Full Text] [Related]

  • 32. Therapeutic efficacy of 188Re-MN-16ET lipiodol in an animal model of hepatocellular carcinoma.
    Huang PW, Tsai SC, Luo TY, Kao CH, Lin WY.
    Ann Nucl Med; 2013 Jul; 27(6):532-7. PubMed ID: 23479326
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Intra-arterial administration of sodium borocaptate (BSH)/lipiodol emulsion delivers B-10 to liver tumors highly selectively for boron neutron capture therapy: experimental studies in the rat liver model.
    Suzuki M, Masunaga S, Kinashi Y, Nagata K, Sakurai Y, Nakamatsu K, Nishimura Y, Maruhashi A, Ono K.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):260-6. PubMed ID: 15093923
    [Abstract] [Full Text] [Related]

  • 35. Use of the Oak Ridge National Laboratory tungsten-188/rhenium-188 generator for preparation of the rhenium-188 HDD/lipiodol complex for trans-arterial liver cancer therapy.
    Jeong JM, Knapp FF.
    Semin Nucl Med; 2008 Mar 01; 38(2):S19-29. PubMed ID: 18243839
    [Abstract] [Full Text] [Related]

  • 36. Patient-specific radiation dosimetry for radionuclide therapy of liver tumors with intrahepatic artery rhenium-188 lipiodol.
    Zanzonico PB, Divgi C.
    Semin Nucl Med; 2008 Mar 01; 38(2):S30-9. PubMed ID: 18243841
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pyrazolyl derivatives as bifunctional chelators for labeling tumor-seeking peptides with the fac-[M(CO)3]+ moiety (M = 99mTc, Re): synthesis, characterization, and biological behavior.
    Alves S, Paulo A, Correia JD, Gano L, Smith CJ, Hoffman TJ, Santos I.
    Bioconjug Chem; 2005 Mar 01; 16(2):438-49. PubMed ID: 15769099
    [Abstract] [Full Text] [Related]

  • 39. Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin.
    Moustapha ME, Ehrhardt GJ, Smith CJ, Szajek LP, Eckelman WC, Jurisson SS.
    Nucl Med Biol; 2006 Jan 01; 33(1):81-9. PubMed ID: 16459262
    [Abstract] [Full Text] [Related]

  • 40. [Intrahepatic microvascular changes after intrahepatic arterial injection of lipiodol in normal and cirrhotic rats].
    Ohkusa A.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Jun 25; 52(6):774-85. PubMed ID: 1322524
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.